Quick Takeaways
- Full Succeed International Ltd filed SCHEDULE 13G for 20/20 Biolabs, Inc. Common Stock, par value $0.01.
- Disclosed ownership: 6.3%.
- Date of event: 19 Feb 2026.
Full Succeed International Ltd - 19 Feb 2026 SCHEDULE 13G Report for 20/20 Biolabs, Inc. Common Stock, par value $0.01
- Filing Manager
- Full Succeed International Ltd
- Reporting Manager
- Full Succeed International Limited
- Shares outstanding
- 10,340,714 shares
- Disclosed Ownership
- 651,465 shares
- Ownership
- 6.3%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Mar 2026, 17:18:30 UTC
- Date of event
- 19 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Full Succeed International Ltd disclosed 6.3% ownership in 20/20 Biolabs, Inc. Common Stock, par value $0.01 on 19 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Mar 2026, 17:18.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Full Succeed International Limited | 6.3% | 651,465 | 651,465 | 0 | /s/ Nengyuan Pan | Nengyuan Pan, Director | |
| Nengyuan Pan | 6.3% | 651,465 | 0 | 651,465 | /s/ Nengyuan Pan | Nengyuan Pan | |
| Wei Lu | 6.3% | 651,465 | 0 | 651,465 | /s/ Wei Lu | Wei Lu |